Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.3079
Abstract: Key Points Question Does prevalence of strongyloidiasis interact with the relative risk (RR) of mortality in ivermectin trials for the treatment of COVID-19? Findings In this meta-analysis of 12 randomized clinical trials involving 3901 patients,… read more here.
Keywords: covid regions; strongyloidiasis; prevalence strongyloidiasis; prevalence ... See more keywords